Agendia
MammaPrint® + BluePrint® provides you with actionable insights throughout your patient’s breast cancer journey.
209 employees · est. 2003 · Irvine, United States
BioPorto Diagnostics A/S is the older company (2003 vs 1995); Agendia is the larger of the two.
Side-by-Side Comparison
| Metric | Agendia | BioPorto Diagnostics A/S |
|---|---|---|
| Founded | ||
| Founded | 2003 | 1995 older |
| Headquarters | ||
| Headquarters | Irvine, United States | Denmark |
| Employees | ||
| Employees | 209 larger | 46 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Private Equity | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $176.05M | $81.51M |
| Funding Rounds | ||
| Funding Rounds | 9 | 2 |
| Services | ||
| Services | Genomic Testing Platforms, Molecular Subtyping, Data Analysis for Treatment Planning, Clinical Trial Support | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare Providers, Medical Institutions, Breast Cancer Patients, Patient Advocacy Partners, Research Institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Precision Oncology, Genomic Profiling, Molecular Subtyping, Cancer Recurrence Assay, Clinical Evidence, Real World Evidence, Treatment Guidelines, Next-Generation Diagnostics, Personalized Treatment, Breast Cancer, Genomic Testing, Medical Research, Digital Treatment Tools, Clinical Decision Support, Biopsy Analysis | Not tracked yet |
| Website | ||
| Website | agendia.com | bioporto.com |
About Agendia
Agendia is a precision oncology company headquartered in Irvine, California, committed to providing patients with early stage breast cancer and their physicians the information they need to make the best treatment decisions. The company currently offers two commercially-available genomic profiling t...
About BioPorto Diagnostics A/S
BioPorto Diagnostics A/S is a biotechnology company based in Denmark, founded in 1995. The company is dedicated to developing actionable biomarkers to improve patient management and save lives. Their flagship products, based on the NGAL biomarker, are designed to aid in the risk assessment and diagn...
We will tell you when either one moves
BounceWatch watches Agendia and BioPorto Diagnostics A/S for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Agendia and BioPorto Diagnostics A... — by email.
Frequently Asked Questions
Compare Agendia with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Agendia on 7 Feb 2025, and BioPorto Diagnostics A/S on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.